Osteoscreen, Inc.
Records under this name other than the patents Osteoscreen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,649,631 | Compositions and methods for treating bone deficit conditions Formerly held Term ended Term ended Nov 19, 2019 · From the USPTO record | Term ended | Term ended Nov 19, 2019 | From the USPTO record |
| US 6,838,436 | Inhibitors of proteasomal activity for stimulating bone growth Formerly held Term ended Term ended Jul 2, 2019 · From the USPTO record | Term ended | Term ended Jul 2, 2019 | From the USPTO record |
| US 6,656,904 | Inhibitors of Proteasomal Activity for Stimulating Hair Growth Formerly held Term ended Term ended Aug 12, 2018 · Medium confidence | Term ended | Term ended Aug 12, 2018 | Medium confidence |
| US 6,462,019 | Inhibitors of proteasomal activity and production for stimulating bone growth Formerly held Term ended Term ended Jul 10, 2018 · From the USPTO record | Term ended | Term ended Jul 10, 2018 | From the USPTO record |
| US 6,884,769 | Inhibitors of proteasomal activity for stimulating hair growth Formerly held Term ended Term ended Jul 10, 2018 · From the USPTO record | Term ended | Term ended Jul 10, 2018 | From the USPTO record |
| US 6,080,779 | Compositions and methods for stimulating bone growth Formerly held Term ended Term ended Jun 12, 2018 · From the USPTO record | Term ended | Term ended Jun 12, 2018 | From the USPTO record |
| US 7,101,907 | Topical Administration of Statins for Treatment of Bone Disorders Formerly held Term ended Ended no later than Feb 19, 2018 · Low confidence | Term ended | Ended no later than Feb 19, 2018 | Low confidence |
| US 6,022,887 | Compositions and methods for stimulating bone growth Formerly held Term ended Term ended Dec 12, 2017 · From the USPTO record | Term ended | Term ended Dec 12, 2017 | From the USPTO record |
| US 6,376,476 | Isoprenoid pathway inhibitors for stimulating bone growth Formerly held Term ended Term ended Dec 12, 2017 · From the USPTO record | Term ended | Term ended Dec 12, 2017 | From the USPTO record |
| US 6,642,216 | A Method to Identify Compounds for Treating Bone Disorders Formerly held Term ended Term ended Dec 12, 2017 · Medium confidence | Term ended | Term ended Dec 12, 2017 | Medium confidence |